US Stock MarketDetailed Quotes

INMB INmune Bio

Watchlist
  • 4.870
  • +0.110+2.31%
Close Nov 22 16:00 ET
  • 4.870
  • 0.0000.00%
Post 20:02 ET
108.35MMarket Cap-2233P/E (TTM)

INmune Bio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

INmune Bio Q3 2024 Earnings Date

Currency：USDOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
0
0
0
-100.00%
-100.00%
--
EPS
-0.50
-0.60
-0.10
Miss Est.
-3.48%
-25.00%
-20.82%
Analyst Rating
Strong Buy

Nov 1, 2024

INmune Bio Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Oct 31, 20242024/Q30.000 / 0.000--
Aug 1, 20242024/Q20.000 / 4.670K--
May 9, 20242024/Q114.000K / 14.000K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Oct 31, 20242024/Q30.000 / 0.000--
Aug 1, 20242024/Q20.000 / 4.670K--
May 9, 20242024/Q114.000K / 14.000K--

Unlock Free Earnings Estimates

INmune Bio Earnings Reports

  • INmune Bio | 8-K: INmune Bio Inc. Announces Third Quarter 2024 Results and Provides Business Update

    Nov 2 04:27

  • INmune Bio | 10-Q: Q3 2024 Earnings Report

    Nov 1 04:06

  • INmune Bio | 8-K: INmune Bio Inc. Announces Second Quarter 2024 Results and Provides Business Update

    Aug 3 04:05

  • INmune Bio | 10-Q: Q2 2024 Earnings Report

    Aug 2 04:07

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 1, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data